ADMA Biologics Inc (ADMA)
6.54
+0.10
(+1.55%)
USD |
NASDAQ |
Apr 26, 16:00
6.54
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Market Cap: 1.493B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.470B |
| April 24, 2024 | 1.474B |
| April 23, 2024 | 1.493B |
| April 22, 2024 | 1.415B |
| April 19, 2024 | 1.431B |
| April 18, 2024 | 1.415B |
| April 17, 2024 | 1.378B |
| April 16, 2024 | 1.406B |
| April 15, 2024 | 1.365B |
| April 12, 2024 | 1.374B |
| April 11, 2024 | 1.420B |
| April 10, 2024 | 1.378B |
| April 09, 2024 | 1.394B |
| April 08, 2024 | 1.420B |
| April 05, 2024 | 1.458B |
| April 04, 2024 | 1.433B |
| April 03, 2024 | 1.449B |
| April 02, 2024 | 1.470B |
| April 01, 2024 | 1.493B |
| March 28, 2024 | 1.506B |
| March 27, 2024 | 1.538B |
| March 26, 2024 | 1.483B |
| March 25, 2024 | 1.458B |
| March 22, 2024 | 1.436B |
| March 21, 2024 | 1.413B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.442B |
| March 19, 2024 | 1.413B |
| March 18, 2024 | 1.356B |
| March 15, 2024 | 1.367B |
| March 14, 2024 | 1.374B |
| March 13, 2024 | 1.429B |
| March 12, 2024 | 1.420B |
| March 11, 2024 | 1.410B |
| March 08, 2024 | 1.447B |
| March 07, 2024 | 1.406B |
| March 06, 2024 | 1.397B |
| March 05, 2024 | 1.324B |
| March 04, 2024 | 1.305B |
| March 01, 2024 | 1.260B |
| February 29, 2024 | 1.223B |
| February 28, 2024 | 1.228B |
| February 27, 2024 | 1.260B |
| February 26, 2024 | 1.232B |
| February 23, 2024 | 1.200B |
| February 22, 2024 | 1.189B |
| February 21, 2024 | 1.171B |
| February 20, 2024 | 1.164B |
| February 16, 2024 | 1.194B |
| February 15, 2024 | 1.221B |
| February 14, 2024 | 1.205B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
129.52M
Minimum
Mar 18 2020
1.538B
Maximum
Mar 27 2024
460.84M
Average
279.39M
Median
Nov 27 2019
Market Cap Benchmarks
| Vanda Pharmaceuticals Inc | 265.25M |
| ANI Pharmaceuticals Inc | 1.376B |
| Ligand Pharmaceuticals Inc | 1.249B |
| Puma Biotechnology Inc | 242.48M |
| Bristol-Myers Squibb Co | 90.72B |
Market Cap Related Metrics
| PS Ratio | 5.673 |
| Price to Book Value | 11.04 |
| Price to Free Cash Flow | 383.54 |
| Price | 6.54 |
| Earnings Yield | -1.99% |
| Operating PE Ratio | 67.71 |